This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Institut Pasteur. Active years: 2021.
Company Filing History:
1 out of 331 
1 out of 5,383 
1 out of 897 
Years Active: 2021
Title: The Innovative Contributions of Jonathan Vigne
Introduction
Jonathan Vigne is a notable inventor based in Paris, France. He has made significant contributions to the field of molecular imaging, particularly in the context of inflammation. His work has implications for diagnosing and monitoring inflammatory conditions, showcasing the intersection of technology and healthcare.
Latest Patents
Jonathan Vigne holds a patent titled "CD31 as a molecular target for imaging of inflammation." This patent discloses the use of CD31 as a molecular imaging target in the detection of inflammatory conditions. The research demonstrated that administering the radiolabeled peptide P8RI as a CD31 ligand in various rat models of inflammation allows for a detectable signal from activated cells. The findings indicate that CD31 is present in sufficient quantities on these cells, while the noise signal from activated circulating cells and other non-involved organs is minimal. This innovation provides a valuable tool for determining whether a subject suffers from or is at risk of inflammatory conditions, as well as assessing the risk of recurrence after anti-inflammatory treatments.
Career Highlights
Throughout his career, Jonathan Vigne has worked with esteemed organizations such as the National Institute of Health and Medical Research and Assistance Publique-Hôpitaux de Paris. His experience in these institutions has contributed to his expertise in molecular imaging and inflammation research.
Collaborations
Jonathan has collaborated with notable colleagues, including Giuseppina Caligiuri and Sylvie Bay. These partnerships have further enriched his research and innovation in the field.
Conclusion
Jonathan Vigne's work in molecular imaging represents a significant advancement in the understanding and treatment of inflammatory conditions. His patent and collaborations highlight his commitment to improving healthcare through innovative solutions.